Found: 5
Select item for more details and to access through your institution.
First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE.
- Published in:
- Cancer Reports, 2023, v. 6, n. 5, p. 1, doi. 10.1002/cnr2.1804
- By:
- Publication type:
- Article
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1467
- By:
- Publication type:
- Article
p16, HPV, and Cetuximab:What Is the Evidence?
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 811, doi. 10.1634/theoncologist.2016-0433
- By:
- Publication type:
- Article
Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00072
- By:
- Publication type:
- Article